نتایج جستجو برای: dysport

تعداد نتایج: 192  

ژورنال: بینا 2008
رزمجو, حسن, اخلاقی, محمدرضا, دهقانی, علیرضا, شایگان‌نژاد, وحید, صابری, عالیا ,

هدف: تعیین اثر تزریق ساب‌تنون سم بوتولینوم A یا دیسپورت (Dysport) در کاهش دوبینی ناشی از فلج حاد عصب زوج ششم مغزی. روش پژوهش: این کارآزمایی بالینی تصادفی‌شده بر روی 28 بیمار انجام شد. بیماران دچار فلج حاد یک‌طرفه زوج 6 که از بیماری آن‌ها کم‌تر از 3 ماه گذشته و ازوتروپی بیش از 10 پریزم‌دیوپتر در نگاه دور داشتند و فاقد سابقه بیماری‌های خارج چشمی بودند؛ وارد مطالعه شدند. معاینات کامل چشمی شامل...

Objectives: In this study, we examined the effect of botulinum toxin A (BTA) on chronic allergic rhinitis (CAR). We tested the effects of BTA, applied to an intranasal sponge, on patients who had CAR for a minimum of three years and had been treated unsuccessfully with conventional medications. Methods:The study was an interventional case-control single-blind randomized clinical trial. Forty...

Journal: :journal of current ophthalmology 0
محمدرضا طالب نژاد mohammad-reza talebnejad محمد شریفی mohammad sharifi محمدحسین نوروززاده mohammad-hossein nowroozzadeh

purpose : the aim of this study is to evaluate the effectiveness of intraoperative botulinum toxin-a (bta) injection as an adjunct to the surgical treatment of large-angle esotropia or exotropia. methods : thirteen patients were included in this interventional case series study. mean age of the patients was 23.31±13.29 years (range: 5-43 years). of these 13 patients, 6 were exotropic and 7 were...

2016
Jonathan Bank Nicole A. Phillips Laurie A. Casas

Aim: Incobotulinumtoxin A (xeomin) has been proposed as an alternative to abobotulinumtoxin A (dysport) and onabotulinumtoxin A (Botox) in the treatment of glabellar frown lines. A recent study is comparing abobotulinumtoxin A and onabotulinumtoxin A revealed equivalent efficacy with a dose conversion ratio of 2.5:1. We sought to establish effectiveness and dosing equivalency of incobotulinumto...

Journal: :anesthesiology and pain medicine 0
seyed m. jazayeri department of physical medicine and rehabilitation, shiraz university of medical sciences, shiraz, iran alireza ashraf department of physical medicine and rehabilitation, shiraz university of medical sciences, shiraz, iran habib m. fini department of physical medicine and rehabilitation, shiraz university of medical sciences, shiraz, iran hajar karimian department of physical medicine and rehabilitation, shiraz university of medical sciences, shiraz, iran; department of physical medicine and rehabilitation, shahid faghihi hospital, shiraz university of medical sciences, zand st., shiraz, iran. tel.: +98-7112319040, fax: +98-7112319040 mohamadreza v. nasab department of physical medicine and rehabilitation, shahid sadughi university of medical sciences, yazd, iran

conclusions bont-a improves clbp with a low incidence of side effects and can be used as a therapeutic tool in the management of these patients. results after 4 weeks, 76% of patients in the bont-a group reported pain relief compared to 20% in the saline group (p < 0. 005). additionally, greater pain relief was experienced by patients in the bont-a group at 8 weeks (64% vs. 12%; p < 0. 001). by...

Journal: :journal of research in medical sciences 0
sayed mojtaba abtahi department of otolaryngology, school of medicine, isfahan university of medical sciences, isfahan, iran sayed mostafa hashemi department of otolaryngology, school of medicine, isfahan university of medical sciences, isfahan, iran sayed hamidreza abtahi department of otolaryngology, school of medicine, isfahan university of medical sciences, isfahan, iran bagher bastani department of otolaryngology, school of medicine, isfahan university of medical sciences, isfahan, iran

normal 0 false false false en-us x-none ar-sa background: botulinum toxin a (bta) is a promising therapeutic option in the treatment of allergic rhinitis (ar). although recent studies have introduced bta septal injection as an alternative method, the conventional localization for the injection of bta in patients with ar is still the nasal turbinates. this study was designed to compare the effec...

2011
Andy Pickett

Modern clinical use of botulinum toxin (BoNT) by doctors requires evidence-based facts and data to support their work. In particular, these need to be unbiased and complete. Too often in the past, speculative statements have been used and repeated until injectors have come to believe they are solid facts. 1 Yet no supporting data exist. Consequently, doctors have often been reluctant to change ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید